With the science behind the use of hydroxychloroquine (HCQ) to treat COVID-19 far from settled, more than a few people have noted the aggressive campaign against the widely-prescribed anti-malaria drug.
The anti-HCQ push has infected Silicon Valley as well – as tech giants have been labeling pro-hydroxychloroquine content as ‘misinformation’ – most recently banishing a press conference by a group of doctors touting the drug from just about every platform.
To that end, Yale epidemiologist Dr. Harvey Risch has accused Dr. Anthony Fouci of waging a “misinformation campaign” against the drug, according to Just The News.
On Tuesday during an interview on “Good Morning America,” Fauci further downplayed the drug’s purported benefit, claiming that “the overwhelming prevailing clinical trials that have looked at the efficacy of hydroxychloroquine have indicated that it is not effective in [treating] coronavirus disease.“
Risch, however, is sharply criticizing Fauci’s approach to evaluating the drug’s effectiveness, arguing that repeated trials and tests have shown that it is markedly effective at treating COVID-19 so long as it is administered properly.
On Tuesday, Risch went further, charging in an interview with Just the News that Fauci is perpetrating a “misinformation campaign” in his opposition to the drug.
Fauci “has been maintaining a studious position that only randomized controlled trial evidence has any value,” Risch said, “and everything else he calls anecdotal.” –Just The News
In a Newsweek Op-Ed published last week, Risch called HCQ “the key to defeating COVID-19,” and said it was particularly effective in conjunction with one of two antibiotics and zinc, saying it has “shown to be highly effective.”
Risch said the drug could save 100,000 lives if widely deployed.
Meanwhile, Food and Drug Administration (FDA) Commissioner Stephen Hahn noted that some medical observational studies “suggest a benefit” to the drug, also according to Just The News.
“So the FDA looks at all what we call ‘the totality of data,’” Hahn said in a Tuesday morning radio interview with Florida radio host Drew Steele. “There are observational studies that suggest a benefit. There are five randomized trials that did not show a benefit to hydroxychloroquine, both in the prophylactic setting and in the treatment — both early and late.” –Just The News
More recently, Rep. Louie Gohmert (R-TX) announced that he would be taking “zinc, erythromycin and hydroxychloroquine” after being diagnosed with COVID-19 on Wednesday.
If you’re looking for those positive studies, click into this thread:
It’s not perfect as HCQ was also used in Belgium and Spain and later in Italy, but the idea is that Western Europe as a whole never embraced the ‘treat early and often’ strategy. Mostly they tried it with sick patients, didn’t work..moved on
They mainly followed the WHO position
— Gummi Bear (@gummibear737) July 16, 2020
And for an even longer thread on positive reports involving HCQ, click this tweet:
Health officials from China, Korea, India, Taiwan, Malaysia, Bahrain, Turkey, Jordan, United Arab Emirates, Qatar, Morocco, Algeria, Nigeria, Senegal, Cuba, Italy, and 65 scientific studies have shown hydroxychloroquine is effective when used early against COVID19. A thread. pic.twitter.com/ol4Z3VxmkY
— CryptoNephilim (@cryptonephilim) July 29, 2020